(4R)-(3’,4’-二氯苯基)-3,4-二氢-2H-萘-1-酮 | 155748-61-1

• 物质功能分类: 生物 - 细胞培养 - 添加剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: (4R)-(3’,4’-二氯苯基)-3,4-二氢-2H-萘-1-酮
• 中文别名: 舍曲林杂质F
• 英文名称: (4R)-4-(3,4-dichlorophenyl)-1-tetralone
• 英文别名: (4R)-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one；(R)-4-(3,4-Dichlorophenyl)-1-tetralone；(4R)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
• CAS: 155748-61-1
• 化学式: C₁₆H₁₂Cl₂O
• 分子量: 291.177
• InChiKey: JGMBHJNMQVKDMW-LLVKDONJSA-N

物化性质

• 熔点：
  86-88°C
• 溶解度：
  苯（微量）、氯仿（微量）、甲醇（微量）

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (4R)-(3’,4’-二氯苯基)-3,4-二氢-2H-萘-1-酮 生成 N-[(4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide
  参考文献：
  名称：

  Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

  摘要：

  本发明的一个方面涉及药物组合物，其中包含两种或更多活性成分，当它们一起服用时，可用于治疗更年期、情绪障碍、焦虑障碍或认知障碍等疾病。药物组合物的第一成分是镇静药艾司唑仑。药物组合物的第二成分是反式4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺或反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺。本发明还涉及一种治疗更年期、围绝经期、情绪障碍、焦虑障碍和认知障碍的方法。

  公开号：

  US20080293726A1
• 作为产物：
  描述：

  methyl (E,4R)-4-(2,5-cyclohexadienyl)-4-(3,4-dichlorophenyl)-2-butenoate 在 palladium on activated charcoal 盐酸 、 氯磺酸 、 氢气 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 二氯甲烷 、 苯 为溶剂， 反应 31.25h， 生成 (4R)-(3’,4’-二氯苯基)-3,4-二氢-2H-萘-1-酮
  参考文献：
  名称：

  Catalytic Asymmetric Synthesis of Diarylacetates and 4,4-Diarylbutanoates. A Formal Asymmetric Synthesis of (+)-Sertraline

  摘要：

  The intermolecular C-H insertion chemistry of phenyldiazoacetates catalyzed by dirhodium tetrakis((S)-N (dodecylbenzenesulfonyl)prolinate) (Rh-2(S-DOSP)(4)) can be effectively carried out on cyclohexadienes, leading to the asymmetric synthesis of diarylacetates. The reaction of vinyldiazoacetates with cyclohexadienes results in an unprecedented carbenoid reaction that is formally a combined C-H insertion/Cope rearrangement. The synthetic utility of this novel transformation was demonstrated by its utilization in a formal asymmetric synthesis of (+)-sertraline.

  DOI：

  10.1021/ol9905699

文献信息

• Synthesis of 4(S)-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone by SN2 cuprate displacement of an activated chiral benzylic alcohol
  作者：George J. Quallich、Teresa M. Woodall

  DOI：10.1016/s0040-4020(01)88330-7

  日期：1992.11

  Two routes for the preparation of 4(S)-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone are reported. The most efficient route generates a chiral benzylic alcohol by catalytic asymmetric oxazaborolidine reduction of a γ-ketoester that is subsequently activated and displaced in an SN2 manner with a higher order cuprate. Intramolecular Friedel-Crafts cyclization of the resulting t-butylester affords

  报道了制备4（S）-（3,4-二氯苯基）-3,4-二氢-1（2H）-萘酮的两种途径。最有效的途径是通过催化不对称的恶唑硼烷催化的γ-酮酸酯还原反应生成手性苄醇，然后将其活化并以SN2方式用较高级的铜酸盐置换。所得叔丁酯的分子内Friedel-Crafts环化得到标题化合物。
• Asymmetric Hydrogenation of N-Alkyl Ketimines with Phosphine-Free, Chiral, Cationic Ru-MsDPEN Catalysts
  作者：Fei Chen、Tianli Wang、Yanmei He、Ziyuan Ding、Zhiwei Li、Lijin Xu、Qing-Hua Fan

  DOI：10.1002/chem.201002846

  日期：2011.1.24

  (Solvent) free and easy: A phosphine‐free, chiral, cationic Ru–MsDPEN complex [(S,S)‐1] is found to be an efficient catalyst for the enantioselective hydrogenation of a range of often‐problematic N‐alkyl ketimines (see scheme). This new method provides a more practical and greener synthetic approach to optically active amines, particularly N‐alkyl amines, such as Sertraline.

  （溶剂）易用：无膦，手性，阳离子的Ru-MsDPEN络合物[（S，S）-1 ]是有效的催化剂，用于对一系列经常有问题的N烷基酮亚胺进行对映选择性氢化（请参阅方案）。这种新方法为旋光性胺（尤其是N-烷基胺，如舍曲林）提供了一种更实用，更绿色的合成方法。
• [EN] TREATMENT OF CNS DISORDERS WITH TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE AND ITS FORMAMIDE<br/>[FR] TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL AVEC DE LA TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE ET SON FORMAMIDE
  申请人：SEPRACOR INC

  公开号：WO2004024669A1

  公开（公告）日：2004-03-25

  Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.

  用(1R,4S)-转式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺；和(1S,4R)-转式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺来治疗中枢神经系统疾病；并且揭示了制备4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的方法。该方法包括制备N-[4-(3,4-二氯苯基)-1,2,3,4-四氢萘-1-基]甲酰胺的四个异构体，这些异构体也是有用的。
• TREATMENT OF PAIN DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE AND ITS FORMAMIDE
  申请人：Tarantino Paul Michael

  公开号：US20070282007A1

  公开（公告）日：2007-12-06

  Treatment of pain disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- 1 -napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful in treatment of pain disorders.

  使用(1R,4S)-反式-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺和(1S,4R)-反式-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺治疗疼痛疾病。还公开了一种制备4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的方法。该方法包括制备N-[4-(3,4-二氯苯基)-1,2,3,4-四氢萘-1-基]甲酰胺的所有四种异构体，这些异构体在治疗疼痛疾病中也有用。
• Copper-Catalyzed Enantioselective Arylation via Radical-Mediated C–C Bond Cleavage: Synthesis of Chiral ω,ω-Diaryl Alkyl Nitriles
  作者：Guo-Qing Cui、Jing-Cheng Dai、Yan Li、Yuan-Bo Li、Duo-Duo Hu、Kang-Jie Bian、Jie Sheng、Xi-Sheng Wang

  DOI：10.1021/acs.orglett.1c02725

  日期：2021.10.1

  The first example of copper-catalyzed ring-opening, enantioselective arylation of cyclic ketoxime esters to access ω,ω-diaryl alkyl nitriles has been developed in high yield (up to 92% yield) with excellent enantioselectivity (up to 91% ee). Side-arm bis(oxazoline) ligand plays a significant role in this asymmetric catalytic transformation, which provides an efficient route to construct diverse chiral

  铜催化开环、环状酮肟酯对映选择性芳基化获得 ω,ω-二芳基烷基腈的第一个例子已经以高产率（高达 92% 的产率）和优异的对映选择性（高达 91% ee）开发。侧臂双（恶唑啉）配体在这种不对称催化转化中发挥重要作用，为构建多种手性 ω,ω-二芳基烷基腈提供了有效途径。在 ω,ω-二芳基烷基腈进一步衍生为相应的酰胺中也证明了合成效用。